Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache

NCT00274170 is registered in ClinicalTrials.gov with C.R.Darnall Army Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
Lead sponsor
C.R.Darnall Army Medical Center
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2006
Completion date
February 28, 2007
Enrollment
56
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine headache